Biotest AG (Biotest) is principally engaged in the manufacture, development and distribution of bio-chemical, innovative haematology and immunology products. The medicinal products of the company are utilized for the treatment of blood and immune diseases. The operations of the company are carried through two divisions; Pharmaceuticals and Diagnostics. The company principally operates in Europe, America and Asia. It is headquartered in Dreieich, Germany.The company reported revenues of (Euro) EUR 423.0 million during the fiscal year ended December 2008, an increase of 29.6% over 2007. The operating profit of the company was EUR 55.6 million during the fiscal year 2008, an increase of 44.5% over 2007. The net profit of the company was EUR 25.7 million during the fiscal year 2008, an increase of 65.8% over 2007.